Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Feb 13, 2024

SELL
$40.84 - $58.14 $1.85 Million - $2.64 Million
-45,376 Reduced 28.03%
116,527 $5.08 Million
Q1 2023

May 11, 2023

SELL
$40.84 - $58.14 $1.85 Million - $2.64 Million
-45,376 Reduced 28.03%
116,527 $5.08 Million
Q4 2022

Feb 13, 2024

SELL
$43.88 - $56.16 $73,718 - $94,348
-1,680 Reduced 1.03%
161,903 $8.99 Million
Q4 2022

Feb 09, 2023

SELL
$43.88 - $56.16 $73,718 - $94,348
-1,680 Reduced 1.03%
161,903 $8.99 Million
Q2 2022

Feb 13, 2024

BUY
$57.25 - $86.63 $52,670 - $79,699
920 Added 0.57%
163,583 $10.2 Million
Q2 2022

Jul 26, 2022

BUY
$57.25 - $86.63 $52,670 - $79,699
920 Added 0.57%
163,583 $10.2 Million
Q1 2022

Feb 13, 2024

BUY
$71.02 - $86.99 $11.6 Million - $14.2 Million
162,663 New
162,663 $13.3 Million
Q1 2022

May 11, 2022

BUY
$71.02 - $86.99 $109,725 - $134,399
1,545 Added 0.96%
162,663 $13.3 Million
Q4 2021

Feb 11, 2022

SELL
$76.72 - $92.68 $1,534 - $1,853
-20 Reduced 0.01%
161,118 $14.1 Million
Q3 2021

Nov 15, 2021

SELL
$76.02 - $88.62 $869,288 - $1.01 Million
-11,435 Reduced 6.63%
161,138 $12.8 Million
Q2 2021

Aug 12, 2021

SELL
$73.44 - $87.01 $970,876 - $1.15 Million
-13,220 Reduced 7.12%
172,573 $14.5 Million
Q4 2020

Feb 10, 2021

BUY
$46.01 - $68.74 $3.98 Million - $5.94 Million
86,448 Added 87.02%
185,793 $12.3 Million
Q3 2020

Nov 13, 2020

SELL
$41.91 - $57.81 $4.41 Million - $6.09 Million
-105,310 Reduced 51.46%
99,345 $4.49 Million
Q2 2020

Aug 13, 2020

SELL
$39.87 - $56.9 $1.81 Million - $2.58 Million
-45,425 Reduced 18.16%
204,655 $9.85 Million
Q1 2020

May 13, 2020

BUY
$34.22 - $76.49 $1.86 Million - $4.16 Million
54,415 Added 27.81%
250,080 $11.3 Million
Q4 2019

Feb 13, 2020

BUY
$68.92 - $85.27 $2.25 Million - $2.79 Million
32,715 Added 20.08%
195,665 $14.8 Million
Q3 2019

Nov 14, 2019

BUY
$71.74 - $86.35 $583,963 - $702,889
8,140 Added 5.26%
162,950 $12 Million
Q2 2019

Aug 13, 2019

BUY
$66.45 - $97.36 $160,809 - $235,611
2,420 Added 1.59%
154,810 $11.1 Million
Q1 2019

May 14, 2019

BUY
$86.15 - $100.49 $451,856 - $527,070
5,245 Added 3.56%
152,390 $14.8 Million
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $521,247 - $776,976
-6,195 Reduced 4.04%
147,145 $13.5 Million
Q3 2018

Nov 14, 2018

SELL
$101.02 - $130.95 $3.33 Million - $4.31 Million
-32,920 Reduced 17.67%
153,340 $19 Million
Q2 2018

Aug 14, 2018

SELL
$81.75 - $105.37 $298,387 - $384,600
-3,650 Reduced 1.92%
186,260 $18.6 Million
Q1 2018

May 14, 2018

SELL
$79.95 - $89.74 $755,927 - $848,491
-9,455 Reduced 4.74%
189,910 $16.8 Million
Q4 2017

Feb 14, 2018

SELL
$71.8 - $88.21 $610,300 - $749,785
-8,500 Reduced 4.09%
199,365 $15.9 Million
Q3 2017

Nov 14, 2017

SELL
$60.32 - $70.06 $19,604 - $22,769
-325 Reduced 0.16%
207,865 $14.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
208,190
208,190 $12.7 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.55B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Nicholas Company, Inc. Portfolio

Follow Nicholas Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.